针对头部和部状细胞癌的免疫疗法:目前的状况和前景
Amaury Daste1, Mathieu Larroquette1,2,3, Nyere Gibson1,3
1Department of Medical Oncology, Hôpital Saint-André, CHU, Bordeaux, France.
Immunotherapy
|December 21, 2023
概括
免疫检查点抑制剂 (ICI) 现在是头角状细胞癌 (HNSCC) 的标准第一线治疗方法. 本综述总结了关键的III期试验,并讨论了HNSCC的生物标志物和组合疗法.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 免疫检查点抑制剂 (ICI) 已经改变了癌症治疗.
- 头部和部状细胞癌 (HNSCC) 是一种重要的固体癌症.
- 在第一线HNSCC治疗中,ICI越来越多地被使用,通常与化疗一起.
研究的目的:
- 审查复发性或转移性HNSCC中ICI的III期研究.
- 讨论基于PD-L1状态作为预测生物标志物的ICI疗效.
- 探索ICI在本地先进和新辅助HNSCC设置中的使用.
主要方法:
- 主要III期临床试验的系统审查.
- 在HNSCC中分析ICI的疗效数据.
- 预测生物标志物的评估,包括PD-L1表达.
- 评估与向药物的联合疗法.
主要成果:
- 在复发性/转移性HNSCC中,ICI显示出显著的疗效.
- PD-L1状态会影响治疗的指示和结果.
- 在局部先进和新辅助的环境中,正在研究ICI的疗效.
- 与化疗和向疗法的结合显示出有前途.
结论:
- 在先进的HNSCC治疗中,ICI是基石.
- 使用PD-L1等生物标志物的个性化治疗方法至关重要.
- 对组合疗法的进一步研究将扩大HNSCC的治疗选择.
相关概念视频
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Cancer Vaccines
370
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
370
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cytotoxic T Cells-mediated Immune Response
923
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
923


